Evaluation of Chronic Urethritis

Krieger, John N.

doi:10.1001/archinte.1988.00380030209032

Cited by 15 publications

(2 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In about 20-30% ofthe cases of nongonococcal urethritis (NGU), the pathogen is unidentified; and for recurrent and chronic urethritis recognised pathogens are rarely identified (14). Here genital HSV can be one of the possible aetiological agents.…”

Section: Discussionmentioning

confidence: 99%

Atypical genital herpes: Report of five cases

Uusküla

Raukas

2004

Scandinavian Journal of Infectious Diseases

View full text Add to dashboard Cite

Manifestations of human genital herpes virus (HSV) infection are not limited to the typical cluster of genital lesions. Here we present 5 case histories suggestive to clinically atypical genital herpes (HSV detected with the polymerase chain reaction) collected in 2001 from a private outpatient clinic specializing in dermatological and venereal diseases. The clinical presentations included mucopurulent cervicitis, haemorrhagic cystitis, recurrent urethritis, and lower back pain.

show abstract

Section: Discussionmentioning

confidence: 99%

Atypical genital herpes: Report of five cases

Uusküla

Raukas

2004

Scandinavian Journal of Infectious Diseases

View full text Add to dashboard Cite

show abstract

“…• Urological investigation is usually normal unless the patient has urinary flow problems 96,97 and is not recommended. (IV, C)…”

Section: Continuing Symptomsmentioning

confidence: 99%

2016 European guideline on the management of non-gonococcal urethritis

et al. 2016

View full text Add to dashboard Cite

We present the updated International Union against Sexually Transmitted Infections (IUSTI) guideline for the management of non-gonococcal urethritis in men. This guideline recommends confirmation of urethritis in symptomatic men before starting treatment. It does not recommend testing asymptomatic men for the presence of urethritis. All men with urethritis should be tested for Chlamydia trachomatis and Neisseria gonorrhoeae and ideally Mycoplasma genitalium using a nucleic acid amplification test (NAAT) as this is highly likely to improve clinical outcomes. If a NAAT is positive for gonorrhoea, a culture should be performed before treatment. In view of the increasing evidence that azithromycin 1 g may result in the development of antimicrobial resistance in M. genitalium, azithromycin 1 g is no longer recommended as first line therapy, which should be doxycycline 100 mg bd for seven days. If azithromycin is to be prescribed an extended course of 500 mg stat, then 250 mg daily for four days is to be preferred over 1 g stat. In men with persistent NGU, M. genitalium NAAT testing is recommended if not previously undertaken, as is Trichomonas vaginalis NAAT testing in populations where T. vaginalis is detectable in >2% of symptomatic women.

show abstract

Seminal Fluid Findings in Men With Nonbacterial Prostatitis and Prostatodynia

KRIEGER,

BERGER,

ROSS

et al. 1996

Journal of Andrology

View full text Add to dashboard Cite

There is considerable confusion about the effects of prostatitis syndromes on male reproductive physiology. Therefore, we correlated findings on seminal fluid and expressed prostatic secretions from 100 men attending a special prostatitis clinic. These men had symptoms of prostatitis but no evidence of urethritis, acute or chronic bacterial prostatitis, or significant urological abnormalities. All subjects were evaluated following a standardized protocol, including lower urinary tract localization studies, expressed prostatic secretion analyses, and seminal fluid analyses with Bryan‐Leishman staining. Seminal fluid findings were compared in men with inflammation (≥106 leukocytes/ml) in their expressed prostatic secretions, i.e., nonbacterial prostatitis, and men without inflammation in prostatic secretions, i.e., prostatodynia. Of 23 men with inflammation (≥106 leukocytes/ml) in their seminal fluid, 6 (26%) had nonbacterial prostatitis (mean leukocyte concentration 8.6 ± 9.4 × l06/ml of semen) and 17(74%) had prostatodynia (mean leukocyte concentration 6.2 ± 7.0 × 106/ml, not significant) Of 77 men who did not have seminal inflammation, 15 (19%) had nonbacterial prostatitis (mean leukocyte concentration 0.1 ± 0.2 × 106/ml) and 62(81%) had prostatodynia (mean leukocyte concentration 0.1 ± 0.2 × l06/ml, not significant). Men with nonbacterial prostatitis had lower values for several parameters associated with sperm motility, especially the proportion of motile sperm (45% compared with 60% for men with prostatodynia, P = 0.08) and sperm subjective speed score (median 3 compared to 4 for men with prostatodynia, P = 0.03). In summary, a minority of men had seminal inflammation, even among men with nonbacterial prostatitis. There was poor correlation between inflammation in the prostatic secretions and in the semen. Nonbacterial prostatitis, but not seminal inflammation, was associated with reduced sperm motility. Our findings highlight technical issues and the importance of investigating different sites and samples, including the urethra, expressed prostatic secretions, and seminal fluid.

show abstract

Evaluation of Chronic Urethritis

Cited by 15 publications

References 21 publications

Atypical genital herpes: Report of five cases

Atypical genital herpes: Report of five cases

2016 European guideline on the management of non-gonococcal urethritis

Seminal Fluid Findings in Men With Nonbacterial Prostatitis and Prostatodynia

Contact Info

Product

Resources

About